Advanced Search

 

Study ID Status Title Patient Level Data
117395 Active not recruiting PGx6470: Genetics of Mepolizumab (SB240563) Treatment Response in Severe Asthmatics in MEA112997
117397 Active not recruiting WEUSKOP6679:Post-authorization safety Electronic Medical Records database retrospective cohort study of new users of inhaled UMEC/VI or new users of inhaled UMEC in the primary care setting: UK EMR distributed network study
117402 Withdrawn A Continued Access protocol for eligible US subjects with Duchenne Muscular Dystrophy who previously participated in an approved drisapersen study
117410 Recruiting A 24 Week Randomised, Double blind and Placebo controlled Study to Evaluate the Efficacy and Safety of 62.5 mcg Umeclidinium Inhalation Powder Delivered Once daily via a Novel Dry Powder Inhaler in Subjects with Chronic Obstructive Pulmonary Disease
134612/003 Completed Assess the safety, reactogenicity, immunogenicity & long-term persistence of one intramuscular dose of GSK Biologicals' MenACWY conjugate vaccine vs one subcutaneous dose of Mencevax™ ACWY in healthy adults aged 18-25 yrs Study Listed on ClinicalStudyDataRequest.com
200016 Completed An Open-Label Exploratory Study to Investigate the Feasibility of Administering Exenatide by Continuous Subcutaneous Infusion to Healthy Subjects
200017 Not yet recruiting A Questionnaire based Survey of Psychiatrists practicing in India to Determine their Diagnostic and Management Practices for Bipolar Disorders in Clinical Practice
200030 Completed A Pilot Study in Healthy Male Volunteers to Evaluate a Skeletal-Muscle Microbiopsy Technique for Suitability of Use with Dynamic Proteomic Measurement
200056 Active not recruiting A Phase IIb Study Evaluating a Long-Acting Intramuscular Regimen of GSK1265744 plus TMC278 For The Maintenance of Virologic Suppression Following an Induction of Virologic Suppression on an Oral regimen of GSK1265744 plus Abacavir/Lamivudine in HIV-1 Infected, Antiretroviral Therapy-Naive Adult Subjects
200065 Completed Glucagon-like peptide-1 (GLP-1) agonists: Treatment utilization patterns and risk of acute pancreatitis
200072 Completed An Open-label Study to Evaluate the Effects of a Potent CYP3A4 Inducer and the Effects of a pH Elevating Agent on the Repeat Dose Pharmacokinetics of Dabrafenib (GSK2118436) in Subjects with BRAF V600 Mutation Positive Tumors
200078 Active not recruiting PGx6710: Exploratory evaluation of a 2.9KB deletion in BIM gene with efficacy in lapatinib treated Asian subjects from EGF104535
200084 Active not recruiting WEUKBRE6316: EPPICC collaboration: Retrospective study on safety of COMBIVIR Scored tablet among HIV-infected children and adolescents in Europe using EPPICC data
200087 Recruiting Asthma Control in Latin America Study
200088 Active not recruiting Persistence of antibodies after GSK Biologicals’ meningococcal vaccine GSK134612 in healthy children
200089 Completed Physician-practice based cohort study to estimate the burden of herpes zoster and postherpetic neuralgia in Japan
200092 Recruiting An Open Label, Multicenter, Non-Comparative, Phase IV Study of Panitumumab to Characterize its Safety, Tolerability and Activity in Indian Subjects with Previously Treated Wild-Type RAS (KRAS and NRAS), Metastatic Colorectal Cancer
200094 Recruiting COMPASS: COMparison of Self-reported Tolerability with Pazopanib Versus Chemotherapy among Patients with Advanced Soft Tissue Sarcoma in the United States
200096 Completed An open-label, randomised, single-dose, three-way cross over, six sequence study to determine the relative bioavailability of clopidogrel 75mg from two tablet formulations of SB224326 relative to one 75mg reference tablet of clopidogrel in healthy adult human subjects under fasting conditions
200104 Recruiting An Open-Label, Multi-Center Study to Investigate the Objective Response Rate of Dabrafenib in Combination with Trametinib in Subjects with BRAF V600 Mutation-Positive Melanoma
200107 Completed An Open-label, Randomised, Single Dose, Three-Way Crossover, Six Sequence, Pilot Study to Determine the Relative Bioavailability of Montelukast Sodium 5mg from Two Candidate Chewable Tablet Formulations of GW483100 Relative to One 5mg Chewable Tablet of Reference Montelukast Sodium in Healthy Adult Subjects Under Fasting Conditions Study Listed on ClinicalStudyDataRequest.com
200109 Completed A study to compare the addition of umeclidinium bromide (UMEC) to fluticasone furoate (FF)/vilanterol (VI), with placebo plus FF/VI in subjects with Chronic Obstructive Pulmonary Disease (COPD) -Study 1 Study Listed on ClinicalStudyDataRequest.com
200110 Completed A study to compare the addition of umeclidinium bromide (UMEC) to fluticasone furoate (FF)/vilanterol (VI), with placebo plus FF/VI in subjects with Chronic Obstructive Pulmonary Disease (COPD) -Study 2 Study Listed on ClinicalStudyDataRequest.com
200111 Completed A Retrospective Medical Records Review of patients receiving pazopanib therapy for advanced RCC at the Christie Hospital
200115 Completed Bioequivalence Study for an Isotretinoin Pharmaceutical Preparation - capsules. Open, crossover, randomized, single dose, three treatments, three periods and six sequences with meal (breakfast) study

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.